TotalMarketCap

60 Degrees Pharmaceuticals

SXTPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.176 M

$0.90 -5.57%

Close of 6 Nov 2026

As of 6 Nov 2026, 60 Degrees Pharmaceuticals (SXTP) has a market capitalization of $3.18M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.01M

#3458 by revenue

Earnings

-$7.37M

Loss-making

Shares outstanding

3,516,988

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

60 Degrees Pharmaceuticals lists more than one class of stock. Company figures above cover all classes combined.

SXTPW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #467Aptevo TherapeuticsAPVO$3.30M
  2. #468OnconetixONCO$3.27M
  3. #46960 Degrees PharmaceuticalsSXTP$3.18M
  4. #470Ernexa TherapeuticsERNA$3.02M
  5. #471Mustang BioMBIO$2.99M

What if 60 Degrees Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$8,028,710

Per share 8,891,151× higher

Bitcoin $1.53T

$434,419.50

Per share 481,085× higher

Apple $5.02T

$1,426,159

Per share 1,579,356× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for 60 Degrees Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.